NFKB1 and pancreatic neoplasm: In the last years, considerable evidence supports the notion that NFκB and PI3K/Akt signaling pathways play critical roles in human cancers promoting tumor cell survival, tumorigenesis and development of pancreatic tumor resistance [22].